Successful ligelizumab treatment of severe refractory solar urticaria

J Allergy Clin Immunol Pract. 2023 Aug;11(8):2576-2577. doi: 10.1016/j.jaip.2023.01.052. Epub 2023 Feb 15.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Omalizumab / therapeutic use
  • Urticaria* / drug therapy
  • Urticaria, Solar*

Substances

  • ligelizumab
  • Antibodies, Monoclonal, Humanized
  • Omalizumab